Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients-Reference-Cited by-同舟云学术

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

Published:2020-05-11 Issue:4 Volume:30 Page:364-375
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Vera Aguilera Jesus,Paludo Jonas,McWilliams Robert R.,Zhang Henan,Li Ying,Kumar Anagha B.,Failing Jarrett,Kottschade Lisa A.,Block Matthew S.,Markovic Svetomir N.,Dong Haidong,Dronca Roxana S.,Yan Yiyi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference29 articles.

1. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.;Topalian;J Clin Oncol,2014

2. Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology.;Coit;J Natl Compr Canc Netw,2016

3. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.;Ghiringhelli;Cancer Immunol Immunother,2007

4. Chemotherapeutic targeting of cancer-induced immunosuppressive cells.;Alizadeh;Cancer Res,2014

5. Immunological effects of conventional chemotherapy and targeted anticancer agents.;Galluzzi;Cancer Cell,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals;Journal of Drug Targeting;2024-08-07

2. Beyond T cell toxicity – Intrathecal chemokine CXCL13 indicating B cell involvement in immune‐related adverse events following checkpoint inhibition: A two‐case series and literature review;European Journal of Neurology;2024-03-31

3. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases;Journal of Gastrointestinal Surgery;2024-03

4. Investigational Approaches for Treatment of Melanoma Patients Progressing After Standard of Care;The Cancer Journal;2024-03

5. Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?;The Cancer Journal;2024-03